 |
|
|
| |
Final Results of MYR301: A Randomised Phase 3 Study Evaluating the Efficacy and Safety of BLV Monotherapy for Chronic Hepatitis Delta
|
| |
| |
EASL 2025 May 7-10 Amsterdam
Heiner Wedemeyer1,*, Soo Aleman2,*, Antje Blank3, Pietro Andreone4, Pavel Bogomolov5, Vladimir Chulanov6,
Nina Mamonova7, Natalia Geyvandova8, Viacheslav Morozov9, Olga Sagalova10, Tatiana Stepanova11,
Annemarie Berger12, Sandra Ciesek12, Amos Lichtman13, Dmitry Manuilov13, Renee-Claude Mercier13, Sarah Arterburn13, Florence Christian-Cox13, Steve Tseng13, Anu Osinusi13, Julian Schulze zur Wiesch14, Markus Cornberg1,
Stefan Zeuzem15, Maurizia Rossana Brunetto16,17,#, Pietro Lampertico18,19,#
late breaker
|
| |
|
|
|
|
|
